全球動物模型市場(2022-2028 年):市場預測(動物類型/技術/使用/目標/最終用戶)/區域展望/使用潛力/COVID-19 影響/價格趨勢/市場份額
市場調查報告書
商品編碼
1062842

全球動物模型市場(2022-2028 年):市場預測(動物類型/技術/使用/目標/最終用戶)/區域展望/使用潛力/COVID-19 影響/價格趨勢/市場份額

Animal Model Market Size By Animal Type, Technology, Application, Use, End-use, Organizations, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022-2028

出版日期: | 出版商: Global Market Insights Inc. | 英文 590 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於全球範圍內活躍的藥物研發活動,動物模型市場預計將在 2028 年呈指數級增長。

採用各種大小動物模型研究新型冠狀病毒感染(COVID-19)的主要特徵,如 SARS-CoV-2 的病理學、感染和宿主反應等的研究人員和機構正在迅速增加。 .還採用動物模型來評估未來治療和疫苗接種的安全性和有效性,這正在加速行業的擴張。

在動物類型方面,生豬行業預計將在 2021 年增長到超過 6.69 億美元,並在預測期內以約 5.0% 的複合年增長率增長。這種增長是由於豬與人類的遺傳、生理和解剖學相似性。從技術角度來看,預計胚胎幹細胞輸注行業在預測期內的複合年增長率約為 8.2%,到 2021 年的規模約為 27.87 億美元。胚胎幹細胞輸注有望在未來發展,因為它具有成本效益、遺傳材料易於轉移和節省時間等諸多優勢。

本報告探討了全球動物模型市場、市場定義和概述、COVID-19 和其他市場影響因素的分析、監管環境、市場規模趨勢和預測、動物類型和技術。用途、目標、最終用戶、地區/主要國家、競爭環境、主要公司概況等。

目錄

第一章調查方法

第2章執行摘要

第三章動物模型產業的思考

  • 行業分類
  • 產業情況
  • 行業影響因素
    • 生長因子
    • 潛在風險和挑戰
  • 增長潛力
  • COVID-19:影響分析
  • 監管狀態
  • 波特分析
  • 價格分析
  • 競爭形勢
  • PESTEL 分析

第4章動物模型市場:按動物類型

  • 主要趨勢
  • 鼠標
  • 老鼠
  • 兩棲動物
  • 豚鼠
  • 兔子
  • 猴子
  • 倉鼠
  • 其他

第 5 章動物模型市場:通過技術

  • 主要趨勢
  • CRISPR
  • 顯微注射
  • 胚胎幹細胞注射
  • 核移植
  • 其他

第6章動物模型市場:按用途

  • 主要趨勢
  • 研發
    • 傳染病
    • 免疫疾病
    • 癌症
    • 心血管疾病
    • 糖尿病
    • 遺傳病
    • 神經系統疾病
    • 肥胖
    • NAFLD/NASH
    • 腎病
    • 糖尿病眼病
    • 纖維化
    • 微生物菌群
    • 其他
  • 生產/質量控制
  • 學術領域
  • 臨床前使用
    • 傳染病
    • 免疫疾病
    • 癌症
    • 心血管疾病
    • 糖尿病
    • 遺傳病
    • 神經系統疾病
    • 肥胖
    • NAFLD/NASH
    • 腎病
    • 糖尿病眼病
    • 纖維化
    • 微生物菌群
    • 其他
  • 其他

第7章動物模型市場:按目標

  • 主要趨勢
  • 動物

第 8 章動物模型市場:按最終用戶

  • 主要趨勢
  • 公司
    • 製藥
    • 生物科技
    • 化妝品
    • 其他
  • 組織
    • 政府
    • 非政府組織
  • 學術研究機構
  • CRO

第9章動物模型市場:按地區

  • 主要趨勢
  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第 10 章公司簡介

  • 競爭性儀表板
  • Charles River
  • Envigo
  • genOway
  • Harbour BioMed
  • Janvier Labs
  • PharmaLegacy
  • Taconic Biosciences Inc.
  • The Jackson Laboratory
  • TRANS GENIC INC, Ltd.
簡介目錄
Product Code: 4435

The animal model market is projected to witness exponential growth by 2028 due to increasing pharmaceutical research and development activities around the world.

Surging number of investigators and institutions globally are employing a variety of large and small animal models to investigate key features of COVID-19, such as pathology, transmission, and host responses to SARS-CoV-2. Moreover, animal models are also being adopted to assess the safety and efficacy of prospective treatment drugs and vaccinations, which has augmented industry expansion.

The animal model market has been segregated based on end use, animal type, use, technology, application, and region. With respect to animal type, the market has further been classified into hamsters, mice, sheep, rats, monkeys, fish, rabbits, birds, cats, cattles, dogs, pigs, guinea pigs, amphibians, and others. In 2021, the pigs sub-segment was worth more than USD 669 million and is slated to expand at a CAGR of approximately 5.0% over the analysis period. This growth is attributed to the similarity of pigs to humans in terms of genetics, physiology, and anatomy.

From the technology perspective, the animal model market has been bifurcated into laser therapy, CRISPR, nuclear transfer, microinjection, embryonic stem cell injection, and others. The embryonic stem cell injection sub-segment held a valuation of nearly USD 2,787 million in 2021 and is anticipated to progress at a CAGR of around 8.2% through the projected timeline. Embryonic stem cell injection offers several advantages, including cost-effectiveness, easy transfer of genetic material, and timesaving, among others, which is set to boost segmental development in the coming time period.

Based on application, the market has been segmented into preclinical applications, research & development, academics, production and quality control, and others. The animal model market size from the academics sub-segment surpassed USD 315 million in revenue in 2021 and is speculated to witness robust growth through 2028, registering a CAGR of above 9.2% between 2022 and 2028. Growing research activities in colleges and other institutions are likely to bolster segmental expansion.

By use, the animal model market has been divided into veterinary and human. In 2021, the veterinary sub-segment exceeded a valuation of USD 3,451 million and is estimated to grow at about 7.8% CAGR through the review period. Rising prevalence of fatal animal disorders is set to propel segmental progress.

In terms of end-use, the animal model market has been categorized into contract research organizations (CRO), companies, academic and research institutes, and organizations. In 2021, the contract research organizations (CRO) sub-segment garnered a revenue worth USD 1,340 million and is projected to develop at a CAGR of approximately 8.1% over the assessment period. Increasing R&D expenditure and growing number of clinical trials in emerging countries are estimated to drive product uptake in CROs over the forthcoming years.

On the regional front, the Latin America animal model market was valued at around USD 119 million in 2021 and is expected to expand at a sturdy growth rate of nearly 8.0% through the forecast period. Mounting healthcare expenditure, along with rising scientific research activities, is set to foster regional market outlook.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definition
  • 1.2 Base estimates & working
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Animal model industry 360 degree synopsis, 2017 - 2028
    • 2.1.1 Business trends
    • 2.1.2 Animal type trends
    • 2.1.3 Technology trends
    • 2.1.4 Application trends
    • 2.1.5 Use trends
    • 2.1.6 End-use trends
    • 2.1.7 Regional trends

Chapter 3 Animal Model Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2028 (USD Million)
  • 3.3 Industry impact factors
    • 3.3.1 Growth drivers
      • 3.3.1.1 Growing number of pharmaceutical research and development activities
      • 3.3.1.2 Large number of applications in healthcare domain
      • 3.3.1.3 Physiological similarities between human and animal
      • 3.3.1.4 Emergence of CRISPR as a powerful tool in the field of biomedical research
      • 3.3.1.5 Growing consumption of personalized medicine driving the demand for humanized mice models
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Expensive process
      • 3.3.2.2 Strict regulations and guidelines
      • 3.3.2.3 Growing opposition on animal testing by several organizations
  • 3.4 Growth potential analysis
    • 3.4.1 By animal type
    • 3.4.2 By technology
    • 3.4.3 By application
    • 3.4.4 By use
    • 3.4.5 By End-use
  • 3.5 COVID-19 impact analysis
  • 3.6 Regulatory landscape
    • 3.6.1 U.S.
    • 3.6.2 Europe
    • 3.6.3 Asia Pacific
    • 3.6.4 Latin America
    • 3.6.5 Middle East & Africa
  • 3.7 Porter's analysis
  • 3.8 Pricing analysis
  • 3.9 Competitive landscape, 2021
    • 3.9.1 Competitive matrix analysis, 2021
  • 3.10 PESTEL analysis

Chapter 4 Animal Model Market, By Animal Type

  • 4.1 Key segment trends
  • 4.2 Mice
    • 4.2.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.2.2 Market size, by region, 2017 - 2028 (Units)
  • 4.3 Rats
    • 4.3.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.3.2 Market size, by region, 2017 - 2028 (Units)
  • 4.4 Fish
    • 4.4.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.4.2 Market size, by region, 2017 - 2028 (Units)
  • 4.5 Birds
    • 4.5.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.5.2 Market size, by region, 2017 - 2028 (Units)
  • 4.6 Cattles
    • 4.6.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.6.2 Market size, by region, 2017 - 2028 (Units)
  • 4.7 Pigs
    • 4.7.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.7.2 Market size, by region, 2017 - 2028 (Units)
  • 4.8 Amphibians
    • 4.8.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.8.2 Market size, by region, 2017 - 2028 (Units)
  • 4.9 Guinea Pigs
    • 4.9.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.9.2 Market size, by region, 2017 - 2028 (Units)
  • 4.10 Dogs
    • 4.10.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.10.2 Market size, by region, 2017 - 2028 (Units)
  • 4.11 Cats
    • 4.11.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.11.2 Market size, by region, 2017 - 2028 (Units)
  • 4.12 Rabbits
    • 4.12.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.12.2 Market size, by region, 2017 - 2028 (Units)
  • 4.13 Monkeys
    • 4.13.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.13.2 Market size, by region, 2017 - 2028 (Units)
  • 4.14 Sheep
    • 4.14.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.14.2 Market size, by region, 2017 - 2028 (Units)
  • 4.15 Hamsters
    • 4.15.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.15.2 Market size, by region, 2017 - 2028 (Units)
  • 4.16 Others
    • 4.16.1 Market size, by region, 2017 - 2028 (USD Million)
    • 4.16.2 Market size, by region, 2017 - 2028 (Units)

Chapter 5 Animal Model Market, By Technology

  • 5.1 Key segment trends
  • 5.2 CRISPR
    • 5.2.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.3 Microinjection
    • 5.3.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.4 Embryonic Stem Cell Injection
    • 5.4.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.5 Nuclear Transfer
    • 5.5.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.6 Others
    • 5.6.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 6 Animal Model Market, By Application

  • 6.1 Key segment trends
  • 6.2 Research & Development
    • 6.2.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.2.2 Infectious Disease
      • 6.2.2.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.2.3 Immunological Disease
      • 6.2.3.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.2.4 Cancer
      • 6.2.4.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.2.5 Cardiovascular Disease
      • 6.2.5.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.2.6 Diabetes
      • 6.2.6.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.2.7 Genetic Disease
      • 6.2.7.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.2.8 Neurological Disease
      • 6.2.8.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.2.9 Obesity
      • 6.2.9.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.2.10 NAFLD/NASH
      • 6.2.10.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.2.11 Renal Disease
      • 6.2.11.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.2.12 Diabetic Eye Disease
      • 6.2.12.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.2.13 Fibrosis
      • 6.2.13.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.2.14 Microbiome
      • 6.2.14.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.2.15 Others
      • 6.2.15.1 Market size, by region, 2017 - 2028 (USD Million)
  • 6.3 Production & Quality Control
    • 6.3.1 Market size, by region, 2017 - 2028 (USD Million)
  • 6.4 Academics
    • 6.4.1 Market size, by region, 2017 - 2028 (USD Million)
  • 6.5 Preclinical Applications
    • 6.5.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.5.2 Infectious Disease
      • 6.5.2.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.5.3 Immunological Disease
      • 6.5.3.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.5.4 Cancer
      • 6.5.4.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.5.5 Cardiovascular Disease
      • 6.5.5.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.5.6 Diabetes
      • 6.5.6.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.5.7 Genetic Disease
      • 6.5.7.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.5.8 Neurological Disease
      • 6.5.8.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.5.9 Obesity
      • 6.5.9.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.5.10 NAFLD/NASH
      • 6.5.10.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.5.11 Renal Disease
      • 6.5.11.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.5.12 Diabetic Eye Disease
      • 6.5.12.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.5.13 Fibrosis
      • 6.5.13.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.5.14 Microbiome
      • 6.5.14.1 Market size, by region, 2017 - 2028 (USD Million)
    • 6.5.15 Others
      • 6.5.15.1 Market size, by region, 2017 - 2028 (USD Million)
  • 6.6 Others
      • 6.6.1.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 7 Animal Model Market, By Use

  • 7.1 Key segment trends
  • 7.2 Human
    • 7.2.1 Market size, by region, 2017 - 2028 (USD Million)
  • 7.3 Veterinary
    • 7.3.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 8 Animal Model Market, By End-use

  • 8.1 Key segment trends
  • 8.2 Companies
    • 8.2.1 Market size, by region, 2017 - 2028 (USD Million)
    • 8.2.2 Pharmaceutical
      • 8.2.2.1 Market size, by region, 2017 - 2028 (USD Million)
    • 8.2.3 Biotechnology
      • 8.2.3.1 Market size, by region, 2017 - 2028 (USD Million)
    • 8.2.4 Cosmetics
      • 8.2.4.1 Market size, by region, 2017 - 2028 (USD Million)
    • 8.2.5 Others
      • 8.2.5.1 Market size, by region, 2017 - 2028 (USD Million)
  • 8.3 Organizations
    • 8.3.1 Market size, by region, 2017 - 2028 (USD Million)
    • 8.3.2 Government
      • 8.3.2.1 Market size, by region, 2017 - 2028 (USD Million)
    • 8.3.3 Non-government
      • 8.3.3.1 Market size, by region, 2017 - 2028 (USD Million)
  • 8.4 Academic & Research Institutes
      • 8.4.1.1 Market size, by region, 2017 - 2028 (USD Million)
  • 8.5 Contract Research Organizations
      • 8.5.1.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 9 Animal Model Market, By Region

  • 9.1 Key regional trends
  • 9.2 North America
    • 9.2.1 Market size, by country, 2017 - 2028 (USD Million)
    • 9.2.2 Market size, by country, 2017 - 2028 (Units)
    • 9.2.3 Market size, by animal type, 2017 - 2028 (USD Million)
    • 9.2.4 Market size, by animal type, 2017 - 2028 (Units)
    • 9.2.5 Market size, by technology, 2017 - 2028 (USD Million)
    • 9.2.6 Market size, by application, 2017 - 2028 (USD Million)
      • 9.2.6.1 Market size, by research & development, 2017 - 2028 (USD Million)
      • 9.2.6.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
    • 9.2.7 Market size, by use, 2017 - 2028 (USD Million)
    • 9.2.8 Market size, by end-use, 2017 - 2028 (USD Million)
      • 9.2.8.1 Market size, by companies, 2017 - 2028 (USD Million)
      • 9.2.8.2 Market size, by organizations, 2017 - 2028 (USD Million)
    • 9.2.9 U.S.
      • 9.2.9.1 Market size, by animal type, 2017 - 2028 (USD Million)
      • 9.2.9.2 Market size, by animal type, 2017 - 2028 (Units)
      • 9.2.9.3 Market size, by technology, 2017 - 2028 (USD Million)
      • 9.2.9.4 Market size, by application, 2017 - 2028 (USD Million)
        • 9.2.9.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
        • 9.2.9.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
      • 9.2.9.5 Market size, by use, 2017 - 2028 (USD Million)
      • 9.2.9.6 Market size, by end-use, 2017 - 2028 (USD Million)
        • 9.2.9.6.1 Market size, by companies, 2017 - 2028 (USD Million)
        • 9.2.9.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
    • 9.2.10 Canada
      • 9.2.10.1 Market size, by animal type, 2017 - 2028 (USD Million)
      • 9.2.10.2 Market size, by animal type, 2017 - 2028 (Units)
      • 9.2.10.3 Market size, by technology, 2017 - 2028 (USD Million)
      • 9.2.10.4 Market size, by application, 2017 - 2028 (USD Million)
        • 9.2.10.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
        • 9.2.10.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
      • 9.2.10.5 Market size, by use, 2017 - 2028 (USD Million)
      • 9.2.10.6 Market size, by end-use, 2017 - 2028 (USD Million)
        • 9.2.10.6.1 Market size, by companies, 2017 - 2028 (USD Million)
        • 9.2.10.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
    • 9.3 Europe
      • 9.3.1 Market size, by country, 2017 - 2028 (USD Million)
      • 9.3.2 Market size, by country, 2017 - 2028 (Units)
      • 9.3.3 Market size, by animal type, 2017 - 2028 (USD Million)
      • 9.3.4 Market size, by animal type, 2017 - 2028 (Units)
      • 9.3.5 Market size, by technology, 2017 - 2028 (USD Million)
      • 9.3.6 Market size, by application, 2017 - 2028 (USD Million)
        • 9.3.6.1 Market size, by research & development, 2017 - 2028 (USD Million)
        • 9.3.6.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
      • 9.3.7 Market size, by use, 2017 - 2028 (USD Million)
      • 9.3.8 Market size, by end-use, 2017 - 2028 (USD Million)
        • 9.3.8.1 Market size, by companies, 2017 - 2028 (USD Million)
        • 9.3.8.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.3.9 Germany
        • 9.3.9.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.3.9.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.3.9.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.3.9.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.3.9.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.3.9.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.3.9.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.3.9.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.3.9.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.3.9.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.3.10 UK
        • 9.3.10.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.3.10.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.3.10.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.3.10.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.3.10.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.3.10.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.3.10.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.3.10.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.3.10.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.3.10.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.3.11 France
        • 9.3.11.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.3.11.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.3.11.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.3.11.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.3.11.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.3.11.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.3.11.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.3.11.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.3.11.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.3.11.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.3.12 Spain
        • 9.3.12.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.3.12.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.3.12.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.3.12.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.3.12.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.3.12.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.3.12.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.3.12.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.3.12.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.3.12.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.3.13 Italy
        • 9.3.13.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.3.13.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.3.13.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.3.13.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.3.13.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.3.13.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.3.13.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.3.13.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.3.13.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.3.13.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.3.14 Switzerland
        • 9.3.14.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.3.14.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.3.14.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.3.14.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.3.14.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.3.14.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.3.14.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.3.14.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.3.14.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.3.14.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.3.15 Netherlands
        • 9.3.15.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.3.15.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.3.15.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.3.15.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.3.15.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.3.15.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.3.15.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.3.15.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.3.15.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.3.15.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.3.16 Czech Republic
        • 9.3.16.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.3.16.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.3.16.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.3.16.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.3.16.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.3.16.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.3.16.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.3.16.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.3.16.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.3.16.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.3.17 Poland
        • 9.3.17.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.3.17.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.3.17.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.3.17.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.3.17.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.3.17.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.3.17.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.3.17.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.3.17.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.3.17.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.3.18 Belgium
        • 9.3.18.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.3.18.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.3.18.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.3.18.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.3.18.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.3.18.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.3.18.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.3.18.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.3.18.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.3.18.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.3.19 Finland
        • 9.3.19.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.3.19.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.3.19.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.3.19.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.3.19.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.3.19.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.3.19.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.3.19.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.3.19.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.3.19.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.3.20 Hungary
        • 9.3.20.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.3.20.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.3.20.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.3.20.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.3.20.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.3.20.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.3.20.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.3.20.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.3.20.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.3.20.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.3.21 Denmark
        • 9.3.21.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.3.21.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.3.21.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.3.21.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.3.21.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.3.21.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.3.21.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.3.21.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.3.21.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.3.21.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.3.22 Ireland
        • 9.3.22.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.3.22.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.3.22.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.3.22.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.3.22.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.3.22.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.3.22.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.3.22.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.3.22.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.3.22.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.3.23 Sweden
        • 9.3.23.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.3.23.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.3.23.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.3.23.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.3.23.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.3.23.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.3.23.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.3.23.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.3.23.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.3.23.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
    • 9.4 Asia Pacific
      • 9.4.1 Market size, by country, 2017 - 2028 (USD Million)
      • 9.4.2 Market size, by country, 2017 - 2028 (Units)
      • 9.4.3 Market size, by animal type, 2017 - 2028 (USD Million)
      • 9.4.4 Market size, by animal type, 2017 - 2028 (Units)
      • 9.4.5 Market size, by technology, 2017 - 2028 (USD Million)
      • 9.4.6 Market size, by application, 2017 - 2028 (USD Million)
        • 9.4.6.1 Market size, by research & development, 2017 - 2028 (USD Million)
        • 9.4.6.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
      • 9.4.7 Market size, by use, 2017 - 2028 (USD Million)
      • 9.4.8 Market size, by end-use, 2017 - 2028 (USD Million)
        • 9.4.8.1 Market size, by companies, 2017 - 2028 (USD Million)
        • 9.4.8.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.4.9 China
        • 9.4.9.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.4.9.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.4.9.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.4.9.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.4.9.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.4.9.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.4.9.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.4.9.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.4.9.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.4.9.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.4.10 Japan
        • 9.4.10.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.4.10.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.4.10.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.4.10.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.4.10.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.4.10.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.4.10.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.4.10.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.4.10.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.4.10.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.4.11 Australia
        • 9.4.11.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.4.11.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.4.11.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.4.11.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.4.11.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.4.11.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.4.11.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.4.11.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.4.11.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.4.11.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.4.12 South Korea
        • 9.4.12.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.4.12.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.4.12.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.4.12.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.4.12.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.4.12.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.4.12.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.4.12.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.4.12.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.4.12.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.4.13 New Zealand
        • 9.4.13.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.4.13.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.4.13.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.4.13.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.4.13.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.4.13.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.4.13.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.4.13.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.4.13.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.4.13.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.4.14 Taiwan
        • 9.4.14.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.4.14.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.4.14.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.4.14.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.4.14.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.4.14.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.4.14.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.4.14.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.4.14.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.4.14.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
    • 9.5 Latin America
      • 9.5.1 Market size, by country, 2017 - 2028 (USD Million)
      • 9.5.2 Market size, by country, 2017 - 2028 (Units)
      • 9.5.3 Market size, by animal type, 2017 - 2028 (USD Million)
      • 9.5.4 Market size, by animal type, 2017 - 2028 (Units)
      • 9.5.5 Market size, by technology, 2017 - 2028 (USD Million)
      • 9.5.6 Market size, by application, 2017 - 2028 (USD Million)
        • 9.5.6.1 Market size, by research & development, 2017 - 2028 (USD Million)
        • 9.5.6.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
      • 9.5.7 Market size, by use, 2017 - 2028 (USD Million)
      • 9.5.8 Market size, by end-use, 2017 - 2028 (USD Million)
        • 9.5.8.1 Market size, by companies, 2017 - 2028 (USD Million)
        • 9.5.8.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.5.9 Brazil
        • 9.5.9.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.5.9.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.5.9.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.5.9.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.5.9.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.5.9.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.5.9.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.5.9.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.5.9.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.5.9.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.5.10 Mexico
        • 9.5.10.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.5.10.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.5.10.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.5.10.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.5.10.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.5.10.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.5.10.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.5.10.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.5.10.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.5.10.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.5.11 Argentina
        • 9.5.11.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.5.11.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.5.11.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.5.11.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.5.11.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.5.11.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.5.11.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.5.11.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.5.11.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.5.11.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
    • 9.6 Middle East & Africa
      • 9.6.1 Market size, by country, 2017 - 2028 (USD Million)
      • 9.6.2 Market size, by country, 2017 - 2028 (Units)
      • 9.6.3 Market size, by animal type, 2017 - 2028 (USD Million)
      • 9.6.4 Market size, by animal type, 2017 - 2028 (Units)
      • 9.6.5 Market size, by technology, 2017 - 2028 (USD Million)
      • 9.6.6 Market size, by application, 2017 - 2028 (USD Million)
        • 9.6.6.1 Market size, by research & development, 2017 - 2028 (USD Million)
        • 9.6.6.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
      • 9.6.7 Market size, by use, 2017 - 2028 (USD Million)
      • 9.6.8 Market size, by end-use, 2017 - 2028 (USD Million)
        • 9.6.8.1 Market size, by companies, 2017 - 2028 (USD Million)
        • 9.6.8.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.6.9 South Africa
        • 9.6.9.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.6.9.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.6.9.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.6.9.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.6.9.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.6.9.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.6.9.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.6.9.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.6.9.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.6.9.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.6.10 Saudi Arabia
        • 9.6.10.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.6.10.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.6.10.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.6.10.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.6.10.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.6.10.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.6.10.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.6.10.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.6.10.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.6.10.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.6.11 UAE
        • 9.6.11.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.6.11.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.6.11.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.6.11.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.6.11.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.6.11.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.6.11.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.6.11.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.6.11.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.6.11.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
      • 9.6.12 Israel
        • 9.6.12.1 Market size, by animal type, 2017 - 2028 (USD Million)
        • 9.6.12.2 Market size, by animal type, 2017 - 2028 (Units)
        • 9.6.12.3 Market size, by technology, 2017 - 2028 (USD Million)
        • 9.6.12.4 Market size, by application, 2017 - 2028 (USD Million)
          • 9.6.12.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
          • 9.6.12.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
        • 9.6.12.5 Market size, by use, 2017 - 2028 (USD Million)
        • 9.6.12.6 Market size, by end-use, 2017 - 2028 (USD Million)
          • 9.6.12.6.1 Market size, by companies, 2017 - 2028 (USD Million)
          • 9.6.12.6.2 Market size, by organizations, 2017 - 2028 (USD Million)

    Chapter 10 Company Profiles

    • 10.1 Competitive dashboard, 2021
    • 10.2 Charles River
      • 10.2.1 Business overview
      • 10.2.2 Financial data
      • 10.2.3 Product landscape
      • 10.2.4 Strategic outlook
      • 10.2.5 SWOT analysis
    • 10.3 Envigo
      • 10.3.1 Business overview
      • 10.3.2 Financial data
      • 10.3.3 Product landscape
      • 10.3.4 Strategic outlook
      • 10.3.5 SWOT analysis
    • 10.4 genOway
      • 10.4.1 Business overview
      • 10.4.2 Financial data
      • 10.4.3 Product landscape
      • 10.4.4 Strategic outlook
      • 10.4.5 SWOT analysis
    • 10.5 Harbour BioMed
      • 10.5.1 Business overview
      • 10.5.2 Financial data
      • 10.5.3 Product landscape
      • 10.5.4 Strategic outlook
      • 10.5.5 SWOT analysis
    • 10.6 Janvier Labs
      • 10.6.1 Business overview
      • 10.6.2 Financial data
      • 10.6.3 Product landscape
      • 10.6.4 Strategic outlook
      • 10.6.5 SWOT analysis
    • 10.7 PharmaLegacy
      • 10.7.1 Business overview
      • 10.7.2 Financial data
      • 10.7.3 Product landscape
      • 10.7.4 Strategic outlook
      • 10.7.5 SWOT analysis
    • 10.8 Taconic Biosciences Inc.
      • 10.8.1 Business overview
      • 10.8.2 Financial data
      • 10.8.3 Product landscape
      • 10.8.4 Strategic outlook
      • 10.8.5 SWOT analysis
    • 10.9 The Jackson Laboratory
      • 10.9.1 Business overview
      • 10.9.2 Financial data
      • 10.9.3 Product landscape
      • 10.9.4 Strategic outlook
      • 10.9.5 SWOT analysis
    • 10.10 TRANS GENIC INC, Ltd.
      • 10.10.1 Business overview
      • 10.10.2 Financial data
      • 10.10.3 Product landscape
      • 10.10.4 Strategic outlook
      • 10.10.5 SWOT analysis